The Law Offices of Frank R. Cruz Announces Investigation of Accenture plc (ACN) on Behalf of Investors

The Law Offices of Frank R. Cruz announces an investigation of Accenture plc (“Accenture” or the “Company”) (NYSE: ACN) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On March 21, 2024, Accenture released its second quarter fiscal 2024 financial results, missing consensus estimates and lowering its revenue outlook for the remainder of fiscal 2024 to a growth rate of 1-3%, down from an earlier forecast of 5%. On this news, Accenture’s stock price fell $35.41, or 9.3%, to close at $342.20 per share on March 21, 2024, thereby injuring investors.

Then, on September 17, 2024, Bloomberg reported that Accenture had pushed back the majority of staff promotions by at least six months, “a further indication of the uncertainty roiling the professional-services industry as clients pull back on spending.”

On this news, Accenture’s stock price fell $17.08, or 4.8%, to close at $337.04 per share on September 17, 2024, thereby injuring investors further.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased Accenture securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.